| dc.creator |
Oezcengiz, Erkan |
|
| dc.creator |
Oener, Filiz |
|
| dc.creator |
Coskun-Ari, F. Filiz |
|
| dc.creator |
Eratalay, Aydan |
|
| dc.date |
2010-01-01T01:00:00Z |
|
| dc.date.accessioned |
2021-12-03T12:04:37Z |
|
| dc.date.available |
2021-12-03T12:04:37Z |
|
| dc.identifier |
eb1f3113-8719-45b1-9810-6a7da5ee2ca4 |
|
| dc.identifier |
10.3109/02652040902937666 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/eb1f3113-8719-45b1-9810-6a7da5ee2ca4/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/95629 |
|
| dc.description |
Purpose. DNA-based vaccines encoding viral antigens have been shown to elicit immune responses in animal models. In this study, a plasmid DNA (pDNA) coexpressing the middle envelope protein of hepatitis B virus (HBV) and Interleukin-2 (IL-2) was incorporated into Poly (D, L-lactic-co-glycolic acid) (PLGA) microspheres and three different formulations were investigated for their potential as a vaccine delivery system. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing Hepatitis B surface antigen and Interleukin-2 |
|
| dc.type |
info:eu-repo/semantics/article |
|